Mutations in HIVEP2 are associated with developmental delay, intellectual disability, and dysmorphic features
- PMID: 27003583
- PMCID: PMC4907844
- DOI: 10.1007/s10048-016-0479-z
Mutations in HIVEP2 are associated with developmental delay, intellectual disability, and dysmorphic features
Abstract
Human immunodeficiency virus type I enhancer binding protein 2 (HIVEP2) has been previously associated with intellectual disability and developmental delay in three patients. Here, we describe six patients with developmental delay, intellectual disability, and dysmorphic features with de novo likely gene-damaging variants in HIVEP2 identified by whole-exome sequencing (WES). HIVEP2 encodes a large transcription factor that regulates various neurodevelopmental pathways. Our findings provide further evidence that pathogenic variants in HIVEP2 lead to intellectual disabilities and developmental delay.
Keywords: De novo; Developmental Delay; HIVEP2; Intellectual Disability; Whole-exome sequencing.
Conflict of interest statement
Competing Interests Statement
Megan Cho, Kyle Retterer, Rick Person, Kristin Monaghan, and Lindsay Henderson are employees of GeneDx. Wendy Chung is a consultant to BioReference Laboratories.
Figures


References
-
- Rauch A, et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet. 2012;380(9854):1674–82. - PubMed
-
- Exome Aggregation Consortium (ExAC) Available from: http://exac.broadinstitute.org.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases